Lupin, Allergan Get Support In Pay-For-Delay Fight At 1st Circ.
Manufacturers and generic drug companies have rallied behind Lupin Pharmaceuticals Inc. and Allergan PLC in pay-for-delay litigation at the First Circuit, telling the court Thursday that Loestrin buyers' sweeping definition of...To view the full article, register now.
Already a subscriber? Click here to view full article